"Venture Partners at CU Boulder has announced the first recipients of a new translational funding program designed to advance promising, early-stage therapeutics with strong commercial potential...Led by Distinguished Professor Leslie Leinwand (BioFrontiers Institute, CU Boulder Molecular, Cellular & Developmental Biology), with PhD student Jack Gugel and postdoctoral researchers Thomas Martin and Yuxiao Tan, the team is developing an orally available obesity drug that suppresses appetite without affecting gastric emptying or causing muscle loss."
“For outstanding contributions to new bioresponsive polymeric materials and their applications in tissue engineering and regenerative medicine”
"Venture Partners at CU Boulder has announced the first recipients of a new translational funding program designed to advance promising, early-stage therapeutics with strong commercial potential...Led by Distinguished Professor Leslie Leinwand (BioFrontiers Institute, CU Boulder Molecular, Cellular & Developmental Biology), with PhD student Jack Gugel and postdoctoral researchers Thomas Martin and Yuxiao Tan, the team is developing an orally available obesity drug that suppresses appetite without affecting gastric emptying or causing muscle loss."
